Cargando…
Early vitreomacular separation with delayed macular hole closure after ocriplasmin treatment
Based on the indications, one-third to one-half of patients can achieve full-thickness macular hole (FTMH) closure with or without the separation of vitreomacular adhesion (VMA) within 28 days of ocriplasmin treatment. The authors report the case of a 63-year-old man with early VMA separation and de...
Autores principales: | Liang, I-Chia, Wang, Kai, Chien, Hsiang-Wen, Lin, Szu-Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869461/ https://www.ncbi.nlm.nih.gov/pubmed/27146933 http://dx.doi.org/10.4103/0301-4738.181746 |
Ejemplares similares
-
Cost-effectiveness of ocriplasmin for the treatment of vitreomacular traction and macular hole
por: Bennison, Craig, et al.
Publicado: (2016) -
Surgical Outcome of Vitreomacular Traction Associated With Macular Hole
por: Tayyab, Mashal, et al.
Publicado: (2022) -
Visual function response to ocriplasmin for the treatment of vitreomacular traction and macular hole
por: Jackson, Timothy L., et al.
Publicado: (2017) -
Effect of Funding Source on “Spin” in Studies of Ocriplasmin Therapy for Vitreomacular Traction and Macular Hole
por: Hubschman, Sasha, et al.
Publicado: (2020) -
Predicting the individual probability of macular hole closure following intravitreal ocriplasmin injections for vitreomacular traction release using baseline characteristics
por: Bertelmann, Thomas, et al.
Publicado: (2021)